NAVB

Navidea Biopharmaceuticals Inc.
NAVB

Overview Fund Activity
Delisted

NAVB was delisted on the 5th of October, 2023.

Back to rankings

54 hedge funds and large institutions have $4.93M invested in Navidea Biopharmaceuticals Inc. in 2017 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 15 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
54
Holders Change
-2
Holders Change %
-3.57%
% of All Funds
1.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
10
Reduced
15
Closed
7
Calls
$18K
Puts
$4K
Net Calls
+$14K
Net Calls Change
+$9K

Top Buyers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.85M
2
WS
2
Wedbush Securities
California
$61K
3
Wells Fargo
3
Wells Fargo
California
$69K
4
Cambridge Investment Research Advisors
4
Cambridge Investment Research Advisors
Iowa
$40K
5
Citadel Advisors
5
Citadel Advisors
Florida
$41K

Top Sellers

1
SFS
1
Sowell Financial Services
Arkansas
$190K
2
Goldman Sachs
2
Goldman Sachs
New York
$48K
3
SIM
3
Spark Investment Management
New York
$0
4
UBS Group
4
UBS Group
Switzerland
$48K
5
Jane Street
5
Jane Street
New York
$34K
Name Holding Trade Value Shares
Change 		Shares
Change %
SIM
51
Spark Investment Management
New York
– -$44K -5,312 Closed
SI
52
SII Investments
Wisconsin
– -$30K -3,551 Closed
T. Rowe Price Associates
53
T. Rowe Price Associates
Maryland
– -$29K -3,500 Closed
Millennium Management
54
Millennium Management
New York
– -$25K -2,971 Closed
SIAS
55
Shine Investment Advisory Services
Colorado
– -$8K -980 Closed
Wolverine Trading
56
Wolverine Trading
Illinois
– -$6K -757 Closed
1 2
3